+35.4%
CVS vs RCAT
-2.3%
+37.8%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -2.0% | +1.5% | -0.5% |
| 7D | +4.0% | -1.4% | +5.4% | +4.0% |
| 30D | -2.4% | -3.3% | +0.9% | -2.4% |
| 3M | +2.7% | -43.2% | +45.9% | +2.7% |
| 6M | +21.9% | -43.2% | +65.1% | +21.9% |
| YTD | +24.7% | +5.5% | +19.2% | +22.0% |
| 1Y | +35.4% | -1.6% | +37.1% | +31.4% |
| All | +35.4% | -2.3% | +37.8% | +31.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling